Azam Faraji

Azam Faraji

Auto-generated profile, based on publicly available information

Azam Faraji

Maternal-fetal medicine Research Center, Department of Obstetrics and Gynecology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2020 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
MKMaryam Kasraeian
Maryam Kasraeian
MZMarjan Zare
Marjan Zare
HVHomeira Vafaei
Homeira Vafaei
NANasrin Asadi
Nasrin Asadi
AFAzam Faraji
Azam Faraji
SRShohreh Roozmeh
Shohreh Roozmeh
Background: The new SARS-CoV-2 originated from Wuhan, China is spreading rapidly worldwide. A number of SARS-CoV-2 positive pregnant women have been reported. However, more information is still needed on the pregnancy outcome and the neonates regarding COVID-19 pneumonia. Material and Methods: A systematic search was done and nine articles on COVID-19 pneumonia and SARS-CoV-2 positive pregnant women were extracted. Some maternal-fetal characteristics were extracted to be included in the meta-analysis. Results: The present meta-analysis was conducted on 87 SARS-CoV-2 positive pregnant women. Almost 65% of the patients reported a history of exposure to an infected person, 78% suffered from mild or moderate COVID-19, 99.9% had successful termination, 86% had cough, and 68% had fever (p = .022 and p < .001). The overall proportions of vertical transmission, still birth, and neonatal death were zero, 0.002, and, 0.002, respectively (p = 1, p = .86, and p = .89, respectively). The means of the first- and fifth-minute Apgar scores were 8.86 and 9, respectively (p < .001 for both). The confounding role of history of underlying diseases with an estimated overall proportion of 33% (p = .03) resulted in further investigations due to sample size limitation. A natural history of COVID-19 pneumonia in the adult population was presented, as well. Conclusion: Currently, no evidence of vertical transmission has been suggested at least in late pregnancy. No hazards have been detected for fetuses or neonates. Although pregnant women are at an immunosuppressive state due to the physiological changes during pregnancy, most patients suffered from mild or moderate COVID-19 pneumonia with no pregnancy loss, proposing a similar pattern of the clinical characteristics of COVID-19 pneumonia to that of other adult populations.

10 July 2019 in International Journal of Gynecology & Obstetrics
Verified
Journal Article
Closed access
PDF file
NANasrin Asadi
Nasrin Asadi
AFAzam Faraji
Azam Faraji
AKAmeneh Keshavarzi
Ameneh Keshavarzi
MAMojgan Akbarzadeh‐Jahromi
Mojgan Akbarzadeh‐Jahromi
SYSedigeh Yoosefi
Sedigeh Yoosefi

1 January 2021 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
AFAzam Faraji
Azam Faraji
MAMaryam Aghdaki
Maryam Aghdaki
KHKamran Hessami
Kamran Hessami
AHAyda Hosseinkhani
Ayda Hosseinkhani
SRShohreh Roozmeh
Shohreh Roozmeh
LFLeila Foroughinia
Leila Foroughinia

1 December 2018 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
ZPZohreh Safari Pour
Zohreh Safari Pour
AHAyda Hosseinkhani
Ayda Hosseinkhani
NANasrin Asadi
Nasrin Asadi
HSHadi Raeisi Shahraki
Hadi Raeisi Shahraki
HVHomeira Vafaei
Homeira Vafaei
AFAzam Faraji
Azam Faraji

24 September 2021 in Journal of Obstetrics and Gynaecology
Verified
Journal Article
Closed access
AFAzam Faraji
Azam Faraji
MAMojgan Akbarzadeh-Jahromi
Mojgan Akbarzadeh-Jahromi
SBShima Bahrami
Shima Bahrami
SGSayeh Gharamani
Sayeh Gharamani
HSHadi Raeisi Shahraki
Hadi Raeisi Shahraki
NANasrin Asadi
Nasrin Asadi
This study aimed to assess the maternal features, Vascular Endothelial Growth Factor (VEGF) and Placenta Growth Factor (PLGF) in the Placenta Accreta Spectrum (PAS); then, to determine a predictive value of VEGF and PLGF in the PAS. This prospective case-control study was conducted on 90 pregnant women including 45 PAS, and 45 Normal Placenta (NP). Maternal age, gravidity, C/S, and serum levels of VEGF and PLGF were assessed between NP and PAS, and among NP and PAS sub-groups, including Placenta Accreta (PA), Placenta Increta (PI), and Placenta Percreta (PP). The Multi-gravidity, previous C/S, maternal age, and serum level of PLGF were significantly higher in the PAS group compared to the NP group OR = 42, 8.1, 1.17, and 1.002 (p-value <.05 for all); however, there was no difference regarding serum level of VEGF (p-value >.05). The same differences were seen among NP with PA, PI, and PP sub-groups (p-value <.05 for all, but p-value >.05 for VEGF). Placenta Previa was uniformly distributed across the PAS sub-groups (p-value >.05), also the VEGF and PLGF serum levels did not differ between PAS with Previa and PAS without Previa groups (p-value >.05). A valid cut-off point for PLGF was reported at 63.55. A predictive value of PLGF for the PAS patients is presented enjoying high accuracy and generalisability for the study population.

6 March 2021 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
HVHomeira Vafaei
Homeira Vafaei
FKFahimeh Kaveh
Fahimeh Kaveh
NANasrin Asadi
Nasrin Asadi
MKMaryam Kasraeian
Maryam Kasraeian
AFAzam Faraji
Azam Faraji
KBKhadije Bazrafshan
Khadije Bazrafshan
Background: Prenatal corticosteroid administration is known to be an effective strategy in improving fetal pulmonary maturity. This study aimed to evaluate the impact of maternal betamethasone administration on fetal pulmonary and other arteries Doppler velocity and the correlation between RDS development and Doppler indices results. Methods: Fifty one singleton pregnancies between 26 and 34 gestational weeks with a diagnosis of preterm labor were included in the exposed group and received betamethasone. Fifty one uncomplicated pregnancies were included in the non-exposed group. Fetal pulmonary, umbilical and middle cerebral arteries Doppler parameters were evaluated before and 24 to 48 h after steroid administration in the exposed group and two times at same intervals in the non-exposed group. Maternal records were matched to neonatal charts if delivery happened, and demographic and outcome data were abstracted. Results: When compared with the nonexposed group, fetuses treated with corticosteroids demonstrated significantly decreased umbilical artery Pulsatility index (PI) and significantly increased the middle cerebral artery PI, pulmonary artery Acceleration time (AT) and pulmonary artery AT/ET (Ejection time), while all other indices remained similar. We found significantly decreased pulmonary artery AT in the fetuses with respiratory distress syndrome (RDS) compared to those that did not. Conclusions: The results of our study showed that maternal antenatal betamethasone administration caused significant changes in the fetus blood velocity waveforms and also affected the blood flow in the pulmonary artery which led to an increase in the pulmonary artery AT and AT/ET. Among those fetuses with RDS, we found a significant decrease in the pulmonary artery AT, but we did not observe any pulmonary artery AT/ET differences.